Crinetics Pharmaceuticals, Inc. - Common Stock (NQ:CRNX)
Price and Volume
Detailed Quote| Volume | 5,086,346 |
| Open | 83.70 |
| Bid (Size) | 83.50 (200) |
| Ask (Size) | 84.00 (1,100) |
| Prev. Close | 83.67 |
| Today's Range | 83.66 - 83.89 |
| 52wk Range | 25.83 - 83.89 |
| Shares Outstanding | 54,026,103 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Is This Biotech Stock a Buy Near Its 52-Week High? ↗
July 10, 2026
Most active stocks in Tuesday's session ↗
July 07, 2026
Top stock movements in today's session. ↗
July 07, 2026
Monday's after hours session: top gainers and losers ↗
July 06, 2026
Frequently Asked Questions
Is Crinetics Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Crinetics Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Crinetics Pharmaceuticals, Inc. - Common Stock trade on?
Crinetics Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Crinetics Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Crinetics Pharmaceuticals, Inc. - Common Stock is CRNX on the Nasdaq Stock Market
What is the current price of Crinetics Pharmaceuticals, Inc. - Common Stock?
The current price of Crinetics Pharmaceuticals, Inc. - Common Stock is 83.71
When was Crinetics Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Crinetics Pharmaceuticals, Inc. - Common Stock was at 07/14/26 04:00 PM ET
What is the market capitalization of Crinetics Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Crinetics Pharmaceuticals, Inc. - Common Stock is 4.52B
How many shares of Crinetics Pharmaceuticals, Inc. - Common Stock are outstanding?
Crinetics Pharmaceuticals, Inc. - Common Stock has 5B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.